SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,987,098 | -36.7% | 42,362 | -42.6% | 0.41% | -35.5% |
| Q2 2023 | $14,207,012 | -48.8% | 73,818 | -46.1% | 0.64% | -54.5% |
| Q1 2023 | $27,733,126 | +144.8% | 136,974 | +55.4% | 1.40% | +75.7% |
| Q4 2022 | $11,326,871 | +14.0% | 88,140 | +21.4% | 0.80% | -0.6% |
| Q3 2022 | $9,935,000 | +2.9% | 72,608 | +33.0% | 0.80% | +3.6% |
| Q2 2022 | $9,656,000 | -39.0% | 54,572 | -50.4% | 0.77% | -1.4% |
| Q1 2022 | $15,835,000 | +51.0% | 109,928 | +62.1% | 0.78% | +57.0% |
| Q4 2021 | $10,484,000 | +5.2% | 67,816 | +15.5% | 0.50% | -43.2% |
| Q3 2021 | $9,966,000 | -2.3% | 58,692 | -9.2% | 0.88% | 0.0% |
| Q2 2021 | $10,201,000 | -3.2% | 64,612 | -14.8% | 0.88% | -12.3% |
| Q1 2021 | $10,535,000 | -23.8% | 75,871 | -3.8% | 1.00% | -30.4% |
| Q4 2020 | $13,819,000 | – | 78,901 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |